130 related articles for article (PubMed ID: 1760536)
1. Lack of plasma interleukin-1 beta or tumor necrosis factor-alpha elevation during unfavorable hemodialysis conditions.
Powell AC; Bland LE; Oettinger CW; McAllister SK; Oliver JC; Arduino MJ; Favero MS
J Am Soc Nephrol; 1991 Nov; 2(5):1007-13. PubMed ID: 1760536
[TBL] [Abstract][Full Text] [Related]
2. In vitro production of interleukin-1 receptor antagonist in chronic renal failure, CAPD and HD.
Pereira BJ; Poutsiaka DD; King AJ; Strom JA; Narayan G; Levey AS; Dinarello CA
Kidney Int; 1992 Dec; 42(6):1419-24. PubMed ID: 1474775
[TBL] [Abstract][Full Text] [Related]
3. Effects of acetate dialysate on transforming growth factor beta 1, interleukin, and beta 2-microglobulin plasma levels.
Anderson J; Briefel G; Jones JM; Ryu JH; McGuire M; Yun YP
Kidney Int; 1991 Dec; 40(6):1110-7. PubMed ID: 1762311
[TBL] [Abstract][Full Text] [Related]
4. Plasma levels of IL-1 beta, TNF alpha and their specific inhibitors in undialyzed chronic renal failure, CAPD and hemodialysis patients.
Pereira BJ; Shapiro L; King AJ; Falagas ME; Strom JA; Dinarello CA
Kidney Int; 1994 Mar; 45(3):890-6. PubMed ID: 8196293
[TBL] [Abstract][Full Text] [Related]
5. Effects of dialyzer membrane on interleukin-1beta (IL-1beta) and IL-1beta-converting enzyme in mononuclear cells.
Linnenweber S; Lonnemann G
Kidney Int Suppl; 2001 Feb; 78():S282-5. PubMed ID: 11169027
[TBL] [Abstract][Full Text] [Related]
6. Balance between IL-1 beta, TNF-alpha, and their specific inhibitors in chronic renal failure and maintenance dialysis. Relationships with activation markers of T cells, B cells, and monocytes.
Descamps-Latscha B; Herbelin A; Nguyen AT; Roux-Lombard P; Zingraff J; Moynot A; Verger C; Dahmane D; de Groote D; Jungers P
J Immunol; 1995 Jan; 154(2):882-92. PubMed ID: 7814891
[TBL] [Abstract][Full Text] [Related]
7. The effects of peritoneal dialysis and hemodialysis on serum tumor necrosis factor-alpha, interleukin-6, interleukin-10 and C-reactive-protein levels.
Borazan A; Ustün H; Ustundag Y; Aydemir S; Bayraktaroglu T; Sert M; Yilmaz A
Mediators Inflamm; 2004 Jun; 13(3):201-4. PubMed ID: 15223612
[TBL] [Abstract][Full Text] [Related]
8. Plasma lipopolysaccharide binding protein and bactericidal/permeability increasing factor in CRF and HD patients.
Pereira BJ; Sundaram S; Snodgrass B; Hogan P; King AJ
J Am Soc Nephrol; 1996 Mar; 7(3):479-87. PubMed ID: 8704115
[TBL] [Abstract][Full Text] [Related]
9. Acute effect of hemodialysis on serum levels of the proinflammatory cytokines.
Tarakçioğlu M; Erbağci AB; Usalan C; Deveci R; Kocabaş R
Mediators Inflamm; 2003 Feb; 12(1):15-9. PubMed ID: 12745544
[TBL] [Abstract][Full Text] [Related]
10. The study of IL-1 beta, TNF-alpha, IL-6 gene expression and plasma levels on hemodialysis before and after dialyzer reuse.
Qian J; Yu Z; Dai H; Huang P; Zhang Q; Cheng F; Chen S
Chin Med J (Engl); 1997 Jul; 110(7):508-11. PubMed ID: 9594206
[TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-1 receptor antagonist in dialysate and serum from patients on continuous ambulatory peritoneal dialysis.
Brauner A; Hylander B; Wretlind B
Am J Kidney Dis; 1996 Mar; 27(3):402-8. PubMed ID: 8604710
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-8 in chronic renal failure and dialysis patients.
Nakanishi I; Moutabarrik A; Okada N; Kitamura E; Hayashi A; Syouji T; Namiki M; Ishibashi M; Zaid D; Tsubakihara Y
Nephrol Dial Transplant; 1994; 9(10):1435-42. PubMed ID: 7816257
[TBL] [Abstract][Full Text] [Related]
13. Cytokines, adipocytokines and inflammatory markers in patients on continuous ambulatory peritoneal dialysis and hemodialysis.
Oncel M; Akbulut S; Toka Ozer T; Kiyici A; Keles M; Baltaci B; Turk S
Ren Fail; 2016 Aug; 38(7):1071-5. PubMed ID: 27267129
[TBL] [Abstract][Full Text] [Related]
14. Increased production of tumor necrosis factor activity by hemodialysis but not peritoneal dialysis patients.
McKenna RM; Macdonald C; Bernstein KN; Rush DN
Nephron; 1994; 67(2):190-6. PubMed ID: 8072608
[TBL] [Abstract][Full Text] [Related]
15. Cytokine levels during hemodialysis.
Vaziri ND; Kaupke CJ; Yousefi S; Gonzales E; Cesario TC
ASAIO Trans; 1991; 37(3):M389-91. PubMed ID: 1751202
[TBL] [Abstract][Full Text] [Related]
16. Pro- and anti-inflammatory cytokines in chronic pediatric dialysis patients: effect of aspirin.
Goldstein SL; Leung JC; Silverstein DM
Clin J Am Soc Nephrol; 2006 Sep; 1(5):979-86. PubMed ID: 17699316
[TBL] [Abstract][Full Text] [Related]
17. Increased endothelin-1 mRNA expression in peripheral blood monocytes of dialysis patients.
Ebihara I; Nakamura T; Takahashi T; Tomino Y; Shimada N; Koide H
Perit Dial Int; 1997; 17(6):595-601. PubMed ID: 9655160
[TBL] [Abstract][Full Text] [Related]
18. [Concentration of leptin in patients on hemodialysis and peritoneal dialysis].
Zbroch E; Małyszko J; Wołczyński S; Hryszko T; Myśliwiec M
Pol Arch Med Wewn; 1999 Jun; 101(6):503-8. PubMed ID: 10754736
[TBL] [Abstract][Full Text] [Related]
19. Plasma interleukin-18 levels in chronic renal failure and continuous ambulatory peritoneal dialysis.
Chiang CK; Hsu SP; Pai MF; Peng YS; Ho TI; Liu SH; Hung KY; Tsai TJ; Hsieh BS
Blood Purif; 2005; 23(2):144-8. PubMed ID: 15677863
[TBL] [Abstract][Full Text] [Related]
20. Blood serum levels of IL-2, IL-6, IL-8, TNF-alpha and IL-1beta in patients on maintenance hemodialysis.
Rysz J; Banach M; Cialkowska-Rysz A; Stolarek R; Barylski M; Drozdz J; Okonski P
Cell Mol Immunol; 2006 Apr; 3(2):151-4. PubMed ID: 16696903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
